CAMBRIAN BIOTECH PRIVATE LIMITED

Cambrian Biotech Private Limited develops automated systems specifically designed for genomic testing and molecular diagnostics workflows. These devices are intended for precision medicine applications, including oncology, infectious disease diagnostics, and genetic testing. The company’s solutions are engineered to streamline laboratory processes, improving efficiency and accuracy in these specialized areas.

Cambrian Biotech Private Limited is headquartered in India. The company’s location influences its regulatory compliance and market focus, particularly in regions where its devices are registered, such as the European Union.

Cambrian Biotech Private Limited’s devices are listed in the eudamed database, which is the European Union’s central registry for medical devices. This registration is required for devices marketed within the EU, ensuring transparency and compliance with regulatory requirements.

Cambrian Biotech Private Limited’s devices fall under Class A classification. This classification is typically assigned to low-risk medical devices, such as those with minimal or no significant impact on patient safety or health outcomes. The classification determines the regulatory pathway and documentation requirements for market authorization.